GSK-3191607

N/A

Report date: 2023/06/26 09:15:36
NME

Base Information

Drug NameGSK-3191607
Drug Alias NameGSK-607GSK-3191607AGSK-3191607
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionP-type ATPase4 inhibitors
TargetsP-type ATPase4
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A